Calumenin, A Calcium-Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With...

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Calumenin (CALU) is a ubiquitous E-F-hand protein from the CREC family, crucial for calcium homeostasis and cellular functions.
• CALU participates in calcium-dependent activities, extracellular matrix production, and normal/pathologic calcification processes.
• Its involvement extends to inflammatory diseases, cancers, and interactions with vitamin K-dependent proteins.

Purpose of the Study:

• To provide a comprehensive review of Calumenin's molecular aspects and diverse functions.
• To explore CALU's role in physiological processes and pathological conditions, including cancer and immune responses.
• To discuss the implications of CALU isoforms and their regulation in cellular equilibrium and disease.

Main Methods:

• Literature review of existing research on Calumenin.
• Analysis of CALU's molecular functions and interactions.
• Synthesis of findings on CALU's involvement in cellular processes, disease, and therapy response.

Main Results:

• CALU is a multifaceted protein involved in calcium homeostasis, cellular matrix production, and calcification.
• CALU acts as a key regulator in inflammatory diseases and cancers, influencing vitamin K-dependent proteins.
• Opposing functions of CALU isoforms suggest a regulatory balance crucial for cellular equilibrium and disease states.
• CALU's relationship with immune cells and cancer therapy response is significant.

Conclusions:

• Calumenin exhibits diverse and sometimes opposing functions, impacting cellular homeostasis and disease development.
• Understanding CALU isoform balance and regulation is critical for addressing its role in cancer and immune responses.
• Further research into CALU's molecular mechanisms is essential for its therapeutic potential in various pathological conditions.